Full face biostimulator: how to plan the whole face

A full face biostimulator is the planning of the collagen biostimulator for the entire face: instead of "one vial in the jawline," the professional assesses the face as a unit and distributes the treatment across the areas that have lost the most firmness and support. The main goal is usually to improve tissue quality and support, not to create focal volume, which is the role of hyaluronic acid.

This guide is about planning logic, at a review level. It gives no dose per area, dilution, injection plane or product brand. The indication, preparation and technique follow each product's package insert and the decision of the licensed professional, according to the rules of their professional council.

Why plan the whole face, and not just the concern?

Facial aging is global. Skin, fat, ligaments and bone change at the same time, at different rates, and the patient usually perceives only the end effect: "my face looks tired," "my jawline disappeared," "my face has dropped." If the plan treats only the spot the patient points to, the result can end up out of proportion, with one firm area next to a sagging one.

A biostimulator also has a characteristic that favors the big picture: it works over an area, with a gradual tissue response. It makes more sense to think in "treatment areas" than in "points." The full face plan organizes these areas, defines what goes into each session and makes clear what is left for another product or another time.

Who tends to be a good candidate?

Patient selection weighs more than the product. The table summarizes tendencies, which always depend on the individual assessment.

Patient factors influence the response: age, smoking, sun exposure, recent weight loss, autoimmune disease and use of immunosuppressants. These points belong in the medical history in facial harmonization and in the general contraindications.

How to assess the face for a full face plan

A layered assessment helps separate what a biostimulator can improve from what it cannot reach.

1. Skin: thickness, elasticity, texture and photodamage. A biostimulator improves firmness, but does not treat spots or dynamic wrinkles.
2. Fat: position and volume of the fat compartments. Loss of deep volume calls for structural replacement, usually with hyaluronic acid.
3. Ligaments and the musculoaponeurotic layer: laxity of the retaining ligaments and the SMAS explains much of the "descent" of the midface and the jawline.
4. Bone: resorption of the orbit, maxilla and mandible changes the support of all the layers above.

Then look at the face as a whole: from the front, in three-quarter view and in profile, with side lighting and with the patient smiling and at rest. The facial assessment by thirds organizes this reading, and standardized clinical photography is mandatory in this type of plan: since the result is gradual, without a baseline photo there is no way to show progress.

Which areas go into the plan?

The map below is a reference for reasoning, not a protocol. The inclusion of each area depends on the package insert of the chosen product and on the assessment.

Many professionals start with lateral support (temples, lateral midface, jawline) and only then assess what concern remains in the central part of the face. The logic is that firming the lateral side usually reduces the need for product in the medial areas, which carry more risk.

Which areas are usually left out?

Some areas are generally excluded from particulate biostimulators:

• Lips and the highly mobile perioral region, because of nodule risk.
• Periocular region, including the tear trough and the eyelid, because of the thin skin.
• Glabella and nose, because of the high vascular risk.

Many package inserts do not cover or contraindicate these areas. Always check the registered indication of the product you use, because it changes between manufacturers, even within the same class, such as calcium hydroxylapatite.

How to organize the sessions

A full face is rarely resolved in a single visit. The plan is usually split into sessions a few weeks apart, according to the package insert, with reassessment before each new stage.

The initial swelling tends to give a false impression of the result, which fades in the first days. It is worth warning the patient beforehand, because a patient who was not prepared thinks "the product disappeared." The page on biostimulator and swelling helps with this explanation.

How to combine it with hyaluronic acid

A biostimulator and hyaluronic acid answer different questions. The biostimulator improves firmness and quality over an area; hyaluronic acid provides volume, projection and contour at defined points.

In a combined full face plan, a few precautions come up again and again:

• Define the role of each product in each area, so as not to overlap without reason.
• Separate the stages when there is doubt about the response, to know what caused each change.
• Respect each product's package insert regarding areas, interval and combination.
• Use the same photo standard at every stage.

The choice of product by area is detailed in hyaluronic acid by area, and the instrument in cannula or needle.

What are the risks of a full face plan?

Treating more areas means more entry points and more product, so risk management needs to be proportional.

• Nodules, early or late, more common in areas of thin skin or high mobility and when preparation departs from what the manufacturer indicates.
• Swelling and bruising, expected in the first days.
• Irregularity or asymmetry, when the distribution does not follow the patient's anatomy.
• Vascular occlusion, possible with any injectable, with special attention to the temples and the medial midface.
• Response below expectations, which is part of biological variability and should be in the informed consent.

The overview of complications and warning signs is in safety and complications.

Hypothetical example of reasoning

Hypothetical example: a 54-year-old patient with moderate laxity in the midface and jawline, mild temporal hollowing, skin of average thickness and the concern of a "face that is dropping." On assessment, the professional concludes that the loss is more about firmness than volume.

The plan could be described like this, without product figures: a first session focused on lateral support (temples, if the package insert allows, lateral midface and jawline); reassessment after the expected interval; a second session adjusted to the response; and only then a decision about hyaluronic acid at the points that still show loss of projection, such as the chin. The lips and under-eye area would stay out of the biostimulator. The patient leaves knowing that the result is gradual and that the baseline photos are the reference for comparison.

And in Harmy?

For the commercial conversation about the staged plan, see staged plan and assessment consultation.

Checklist before proposing a full face

• Layered assessment recorded, with standardized baseline photos.
• Face map with the areas included and excluded, and the reason.
• Indication for each area checked against the product's package insert.
• Role of each product defined when combined with hyaluronic acid.
• Expected number of sessions and interval explained to the patient.
• Informed consent covering variable response, nodules and the irreversibility of the biostimulator.
• Hyaluronidase available if hyaluronic acid is part of the plan.
• Reassessment date scheduled before the patient leaves.